Literature DB >> 27549308

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

Massimo Gentile1, Tait D Shanafelt2, Davide Rossi3, Luca Laurenti4, Francesca R Mauro5, Stefano Molica6, Giovanna Cutrona7, Giuseppina Uccello1, Melissa Campanelli5, Ernesto Vigna1, Giovanni Tripepi8, Kari G Chaffee9, Sameer A Parikh2, Sabrina Bossio10, Anna Grazia Recchia10, Idanna Innocenti4, Raffaella Pasquale4, Antonino Neri11, Manlio Ferrarini12, Gianluca Gaidano13, Robin Foà5, Fortunato Morabito1,10.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27549308      PMCID: PMC5524531          DOI: 10.1182/blood-2016-07-728261

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Authors:  Tait D Shanafelt; Neil E Kay; Kari G Rabe; David J Inwards; Clive S Zent; Jose F Leis; Susan M Schwager; Carrie A Thompson; Deborah A Bowen; Thomas E Witzig; Susan L Slager; Timothy G Call
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

2.  Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.

Authors:  William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Hagop Kantarjian; Michael Keating
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

3.  The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Authors:  Stefano Molica; Tait D Shanafelt; Diana Giannarelli; Massimo Gentile; Rosanna Mirabelli; Giovanna Cutrona; Luciano Levato; Nicola Di Renzo; Francesco Di Raimondo; Caterina Musolino; Francesco Angrilli; Angelo Famà; Anna Grazia Recchia; Kari G Chaffee; Antonino Neri; Neil E Kay; Manlio Ferrarini; Fortunato Morabito
Journal:  Am J Hematol       Date:  2016-08-08       Impact factor: 10.047

4.  An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.

Authors: 
Journal:  Lancet Oncol       Date:  2016-05-13       Impact factor: 41.316

  4 in total
  17 in total

Review 1.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

3.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

4.  The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites.

Authors:  Anthony Mato; Chadi Nabhan; Nicole Lamanna; Neil E Kay; David L Grinblatt; Christopher R Flowers; Charles M Farber; Matthew S Davids; Arlene S Swern; Kristen Sullivan; E Dawn Flick; Sarah M Gressett Ussery; Mecide Gharibo; Pavel Kiselev; Jeff P Sharman
Journal:  Blood Adv       Date:  2020-04-14

Review 5.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Optimizing frontline therapy of CLL based on clinical and biological factors.

Authors:  Kirsten Fischer; Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia.

Authors:  C Owen; A S Gerrie; V Banerji; S Assouline; C Chen; K S Robinson; E Lye; G Fraser
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

Review 8.  IGHV mutational status testing in chronic lymphocytic leukemia.

Authors:  Jennifer Crombie; Matthew S Davids
Journal:  Am J Hematol       Date:  2017-07-29       Impact factor: 10.047

Review 9.  Prognostication of chronic lymphocytic leukemia in the era of new agents.

Authors:  Barbara Eichhorst; Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

10.  The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.

Authors:  Sameer A Parikh; Kari G Rabe; Neil E Kay; Timothy G Call; Wei Ding; Jose F Leis; Saad S Kenderian; Eli Muchtar; Yucai Wang; Amber B Koehler; Susan M Schwager; Connie E Lesnick; Geffen Kleinstern; Daniel Van Dyke; Curtis A Hanson; Esteban Braggio; Susan L Slager; Tait D Shanafelt
Journal:  Blood       Date:  2021-07-15       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.